Vest Financial LLC Has $52.29 Million Stake in Colgate-Palmolive (NYSE:CL)

Vest Financial LLC raised its position in Colgate-Palmolive (NYSE:CL - Free Report) by 13.9% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 575,181 shares of the company's stock after purchasing an additional 69,982 shares during the period. Vest Financial LLC owned about 0.07% of Colgate-Palmolive worth $52,290,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in CL. Union Bancaire Privee UBP SA acquired a new position in Colgate-Palmolive during the fourth quarter worth approximately $32,000. Hager Investment Management Services LLC acquired a new stake in shares of Colgate-Palmolive during the fourth quarter valued at about $36,000. Reston Wealth Management LLC purchased a new stake in Colgate-Palmolive during the 3rd quarter worth approximately $42,000. Synergy Asset Management LLC acquired a new stake in Colgate-Palmolive in the fourth quarter valued at $49,000. Finally, Capital Performance Advisors LLP bought a new position in shares of Colgate-Palmolive during the third quarter worth about $53,000. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Colgate-Palmolive Trading Down 0.7 %

Colgate-Palmolive stock traded down $0.62 during midday trading on Wednesday, reaching $86.75. The stock had a trading volume of 3,411,852 shares, compared to its average volume of 5,075,059. Colgate-Palmolive has a twelve month low of $82.76 and a twelve month high of $109.30. The company has a debt-to-equity ratio of 9.46, a current ratio of 0.41 and a quick ratio of 0.26. The firm has a market cap of $70.88 billion, a price-to-earnings ratio of 24.64, a PEG ratio of 4.12 and a beta of 0.44. The firm's fifty day simple moving average is $90.00 and its two-hundred day simple moving average is $96.61.

Colgate-Palmolive (NYSE:CL - Get Free Report) last issued its earnings results on Friday, January 31st. The company reported $0.91 EPS for the quarter, beating analysts' consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period in the prior year, the company earned $0.87 EPS. Equities analysts anticipate that Colgate-Palmolive will post 3.73 EPS for the current fiscal year.

Colgate-Palmolive Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 2.31%. The ex-dividend date of this dividend is Tuesday, January 21st. Colgate-Palmolive's dividend payout ratio is currently 56.82%.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on CL shares. Piper Sandler dropped their target price on shares of Colgate-Palmolive from $121.00 to $112.00 and set an "overweight" rating on the stock in a report on Monday, January 6th. JPMorgan Chase & Co. lowered their price target on shares of Colgate-Palmolive from $103.00 to $97.00 and set an "overweight" rating for the company in a research report on Monday, February 3rd. StockNews.com lowered Colgate-Palmolive from a "buy" rating to a "hold" rating in a report on Thursday, January 9th. UBS Group cut their target price on Colgate-Palmolive from $104.00 to $100.00 and set a "buy" rating on the stock in a research note on Monday, February 3rd. Finally, Raymond James reissued an "outperform" rating and issued a $105.00 price target (down previously from $110.00) on shares of Colgate-Palmolive in a research note on Monday, February 3rd. One research analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have given a buy rating to the company. According to data from MarketBeat, Colgate-Palmolive has an average rating of "Hold" and an average target price of $101.16.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.